BibTex RIS Cite

The total synthesis of 2',3'-dihdyro-2'-hydroxyisopropyl-3'-methoxyfuranocoumarin (VII)

Year 1985, Volume: 1 Issue: 1-2, 1 - 5, 17.02.2015

Abstract

-

Year 1985, Volume: 1 Issue: 1-2, 1 - 5, 17.02.2015

Abstract

-

There are 0 citations in total.

Details

Primary Language English
Journal Section Articles
Authors

Solmaz Doğanca This is me

Publication Date February 17, 2015
Published in Issue Year 1985 Volume: 1 Issue: 1-2

Cite

APA Doğanca, S. (2015). The total synthesis of 2’,3’-dihdyro-2’-hydroxyisopropyl-3’-methoxyfuranocoumarin (VII). Marmara Pharmaceutical Journal, 1(1-2), 1-5. https://doi.org/10.12991/mpj.70492
AMA Doğanca S. The total synthesis of 2’,3’-dihdyro-2’-hydroxyisopropyl-3’-methoxyfuranocoumarin (VII). J Res Pharm. February 2015;1(1-2):1-5. doi:10.12991/mpj.70492
Chicago Doğanca, Solmaz. “The Total Synthesis of 2’,3’-Dihdyro-2’-Hydroxyisopropyl-3’-Methoxyfuranocoumarin (VII)”. Marmara Pharmaceutical Journal 1, no. 1-2 (February 2015): 1-5. https://doi.org/10.12991/mpj.70492.
EndNote Doğanca S (February 1, 2015) The total synthesis of 2’,3’-dihdyro-2’-hydroxyisopropyl-3’-methoxyfuranocoumarin (VII). Marmara Pharmaceutical Journal 1 1-2 1–5.
IEEE S. Doğanca, “The total synthesis of 2’,3’-dihdyro-2’-hydroxyisopropyl-3’-methoxyfuranocoumarin (VII)”, J Res Pharm, vol. 1, no. 1-2, pp. 1–5, 2015, doi: 10.12991/mpj.70492.
ISNAD Doğanca, Solmaz. “The Total Synthesis of 2’,3’-Dihdyro-2’-Hydroxyisopropyl-3’-Methoxyfuranocoumarin (VII)”. Marmara Pharmaceutical Journal 1/1-2 (February 2015), 1-5. https://doi.org/10.12991/mpj.70492.
JAMA Doğanca S. The total synthesis of 2’,3’-dihdyro-2’-hydroxyisopropyl-3’-methoxyfuranocoumarin (VII). J Res Pharm. 2015;1:1–5.
MLA Doğanca, Solmaz. “The Total Synthesis of 2’,3’-Dihdyro-2’-Hydroxyisopropyl-3’-Methoxyfuranocoumarin (VII)”. Marmara Pharmaceutical Journal, vol. 1, no. 1-2, 2015, pp. 1-5, doi:10.12991/mpj.70492.
Vancouver Doğanca S. The total synthesis of 2’,3’-dihdyro-2’-hydroxyisopropyl-3’-methoxyfuranocoumarin (VII). J Res Pharm. 2015;1(1-2):1-5.

.